FBRX

$76.86+$0.08 (+0.10%)prev close

Compare

Held by

portfolios on TandT

Bookmarked by

users

Avg position size

—

of holders' portfolios

13F filers

institution

Market cap

$1.6B

20M shares

52-week range

$9.91 – $77.20

99% from low

Sector

PHARMACEUTICAL PREPARATIONS

Exchange

NASDAQ

Change$-518.14

Analyst estimates (consensus)

Year	Est. revenue	Growth	Est. EPS	EPS range	Fwd P/E	# Analysts
2026	$9M	—	$-3.83	$-4.02–$-3.65	—	3
2027	$23M	+150.0%	$-4.04	$-5.42–$-2.65	—	3
2028	$14M	-36.4%	$-3.87	$-5.31–$-2.42	—	2
2029	$32M	+126.6%	$-6.18	$-6.18–$-6.18	—	1

Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep

Earnings surprises

Beat consensus in 5 of the last 8 reported quarters

Reported	Est. EPS	Actual	Surprise
2026-08-11	$-0.99	$-0.97	+2.5%
2026-05-21	$-1.16	$-1.24	-6.9%
2026-03-31	$-1.42	$-1.45	-2.1%
2025-11-14	$-1.04	$-0.99	+4.8%
2025-08-14	$-1.21	$-0.96	+20.7%
2025-05-15	$-0.89	$-1.37	-53.9%
2025-03-24	$-4.55	$-2.45	+46.2%
2024-11-14	$-6.75

DCF fair valuemodel estimate

Intrinsic value

$0.47

Price

$76.86

Implied downside

-99%

Peer comparison

Symbol	Price	Today	Mkt cap	P/E
FBRXForte Biosciences, Inc.	$76.86	+0.10%	$1.6B	—
ACTUActuate Therapeutics Inc	$0.98	-0.48%	$23M	—
ALECAlector, Inc.	$2.04	-5.12%	$226M	—
APLTApplied Therapeutics, Inc.	$0.10	+0.00%	$15M	—
CRBPCorbus Pharmaceuticals Holdings, Inc.	$10.08	+3.28%

Forte Biosciences, Inc. Common Stock

Forte Biosciences Inc is a clinical-stage biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications. The Company is also advancing clinical development of FB102 in patient-based trials for non-segmental vitiligo and alopecia areata.

www.fortebiorx.com

Employees: 22
IPO / List date: Jun 16, 2020
HQ: DALLAS, TX

Held by traders on TradeandTell

No one on the platform currently holds FBRX.

Super investors & insiders

Institutions holding (13F)

Institution	Shares	Reported
Renaissance Technologiesas of 2025-09-30	16,200	$243.0K

Insider activity (SEC Form 4)

Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.

Insider activity (SEC Form 4)

Stock splits

Execution date	Ratio
2024-08-28	1-for-25reverse

Recent trades on TradeandTell

No one on the platform has traded FBRX yet.

$FBRX chatter on StockTwits

nigel bowen@porky1963Bullish3d
$FBRX still looking for some value in BIO so gone for LEXX,INBX.+ SEMG semiconductors.BTEK us biotech may have a chance .HIGHLY UNLIKELY to pick another FBRX but WE will try.x
View on StockTwits ↗
nigel bowen@porky1963Aug 3
$FBRX just to let you know,just sold out.$76.66.DISSAPOINTED in myself but to hold out for more is greed.it's been an epic journey of up and great downs.time to move on.will study over next few weeks if we can get on early again.it was taken out of our hands.x😪
View on StockTwits ↗
nigel bowen@porky1963Aug 3
$FBRX awfull lot go'in on in pharma + biotec stocks.some very big mergers / buyouts on the table if not under the table.some old gold mines out there to reopen.look back in our portfolios just in case of shares sold.maybe its the right time to get back in.x
View on StockTwits ↗
nigel bowen@porky1963BullishJul 30
$FBRX up to asking price.
View on StockTwits ↗
nigel bowen@porky1963Jul 30
$FBRX i am wondering if this "RODEO" is over.after all the years i have been thru here i find it hard that a company that has had to fight tooth+nail to survive has finally decided to be bought out.the price is a bargain for all the hard work done over many years.i hope they keep control of future developments and have the freedom that has brought them on this journey.GREAT TEAM with a great future i hope.thanks for the ride will try and find another winner.x
View on StockTwits ↗
nigel bowen@porky1963BullishJul 29
$FBRX so highly likely saying good bye to my shares.so can you tell me will ARGENX pay the transaction fee and tax on my holding,if not is there any point in holding out until the takeover.they have agreed on$77 .00 a very reasonable price and i do not envisage but i may be wrong someone else turning up to the party.it seems to be moveing very fast from disclosure of the news being released.so is there any advantage to hold out for a few cents/pence.? x.
View on StockTwits ↗
SuperGreenToday@SuperGreenTodayJul 29
$FBRX Share Price: $76.68 Contract Selected: Feb 19, 2027 $70 Calls Buy Zone: $4.33 – $5.35 Target Zone: $7.00 – $8.56 Potential Upside: 53% ROI Time to Expiration: 205 Days | Updates via https://fxcapta.com/stockinfo/
View on StockTwits ↗
Aura@ExploringTradesBullishJul 28
APUS is getting a lot of attention! Could be the next massive runner! Never chase those big moves that are up 500%+ .. Easy way to lose! Key is to buy early before the runs happen! 💎 These tiny float tickers are running 100-400% recently! APUS starting to get discovered and trending on Stocktwits! Only 400k shares outstanding - keep it on watch ! MIght run like $UTZ $CJMB $FBRX Did too now!
View on StockTwits ↗
Green@MrGreenthBullishJul 28
APUS is getting a lot of attention! Could be the next massive runner! Never chase those big moves that are up 500%+ .. Easy way to lose! Key is to buy early before the runs happen! 💎 These tiny float tickers are running 100-400% recently!! APUS starting to get discovered and trending on Stocktwits! Only 400k shares outstanding - keep it on watch bulls! MIght run like $UTZ $CJMB $FBRX Did too
View on StockTwits ↗
Marco@MX1074Jul 28
$FBRX ..200$ before the end of August. Don't forget this post😉
View on StockTwits ↗
Ahmed@tradehulkJul 28
$FBRX $FIG $FRMI 🚨 $CHAI volume up 1300% on expanded TikTok Partnership 🚀
View on StockTwits ↗
Top Stock Alerts@topstockalertsJul 28
$FBRX 👀
View on StockTwits ↗
J. Powell@Powell6531Jul 28
$FBRX $GOSS $KIDZ $MTNB $NCTY
View on StockTwits ↗
Top Stock Alerts@topstockalertsJul 28
Top Gainers PT2 $GOSS $KIDZ $NCTY $FBRX $MTNB
View on StockTwits ↗
PRISM MarketView@prismmarketviewJul 28
🚨 DEAL ALERT: argenx $ARGX is acquiring Forte Biosciences $FBRX for ~$2.2B — $77/share cash, an 86% premium. $FBRX popped ~39% premarket. The prize? FB102, Forte's autoimmune candidate for vitiligo & celiac disease. Read more 👇 #biotech #pharma #MergersAndAcquisitions https://prismmarketview.com/argenx-swoops-on-forte-biosciences-in-2-2-billion-immunology-bet/
View on StockTwits ↗

Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.